These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38087343)

  • 1. Model-based evaluation of admission screening strategies for the detection and control of carbapenemase-producing Enterobacterales in the English hospital setting.
    Pople D; Kypraios T; Donker T; Stoesser N; Seale AC; George R; Dodgson A; Freeman R; Hope R; Walker AS; Hopkins S; Robotham J
    BMC Med; 2023 Dec; 21(1):492. PubMed ID: 38087343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probabilistic microsimulation to examine the cost-effectiveness of hospital admission screening strategies for carbapenemase-producing enterobacteriaceae (CPE) in the United Kingdom.
    Manoukian S; Stewart S; Dancer SJ; Mason H; Graves N; Robertson C; Leonard A; Kennedy S; Kavanagh K; Parcell B; Reilly J
    Eur J Health Econ; 2022 Sep; 23(7):1173-1185. PubMed ID: 34932169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study.
    Kardaś-Słoma L; Fournier S; Dupont JC; Rochaix L; Birgand G; Zahar JR; Lescure FX; Kernéis S; Durand-Zaleski I; Lucet JC
    Antimicrob Resist Infect Control; 2022 Sep; 11(1):117. PubMed ID: 36117231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenemase-producing enterobacterales colonisation status does not lead to more frequent admissions: a linked patient study.
    Lydeamore MJ; Donker T; Wu D; Gorrie C; Turner A; Easton M; Hennessy D; Geard N; Howden BP; Cooper BS; Wilson A; Peleg AY; Stewardson AJ
    Antimicrob Resist Infect Control; 2024 Jul; 13(1):82. PubMed ID: 39075552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England.
    Donker T; Henderson KL; Hopkins KL; Dodgson AR; Thomas S; Crook DW; Peto TEA; Johnson AP; Woodford N; Walker AS; Robotham JV
    BMC Med; 2017 Apr; 15(1):86. PubMed ID: 28446169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical approach to screening for carbapenemase-producing Enterobacterales- views of a group of multidisciplinary experts from English hospitals.
    Jenkins DR; Auckland C; Chadwick C; Dodgson AR; Enoch DA; Goldenberg SD; Hussain A; Martin J; Spooner E; Whalley T
    BMC Infect Dis; 2024 Apr; 24(1):444. PubMed ID: 38671365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of carbapenemase-producing Enterobacterales intestinal colonisation in the elderly population after hospital discharge, Italy, 2018-2020.
    Tinelli M; Rossini A; Scudeller L; Zabzuni D; Errico G; Fogato E; D'Angelo R; Gentiloni Silverj F; Cesana E; Bergamaschini LC; Pasi F; Monaco M; Cerquetti M; Pantosti A; Giufrè M
    Int J Antimicrob Agents; 2022 Jun; 59(6):106594. PubMed ID: 35483624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission.
    Mookerjee S; Dyakova E; Davies F; Bamford K; Brannigan ET; Holmes A; Otter JA
    J Hosp Infect; 2018 Sep; 100(1):15-20. PubMed ID: 29883616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review.
    Bar Ilan M; Kjerulf A
    J Hosp Infect; 2023 Dec; 142():74-87. PubMed ID: 37802236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of enhanced screening for carbapenemase-producing Enterobacterales in an acute care hospital in South Korea.
    Park SH; Yi Y; Suh W; Ji SK; Han E; Shin S
    Antimicrob Resist Infect Control; 2023 Jul; 12(1):62. PubMed ID: 37400884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.
    Otter JA; Dyakova E; Bisnauthsing KN; Querol-Rubiera A; Patel A; Ahanonu C; Tosas Auguet O; Edgeworth JD; Goldenberg SD
    J Antimicrob Chemother; 2016 Dec; 71(12):3556-3561. PubMed ID: 27516471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation.
    Schneider A; Coope C; Michie S; Puleston R; Hopkins S; Oliver I
    BMC Health Serv Res; 2019 Oct; 19(1):689. PubMed ID: 31606053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Xpert
    Hoyos-Mallecot Y; Ouzani S; Dortet L; Fortineau N; Naas T
    Int J Antimicrob Agents; 2017 Jun; 49(6):774-777. PubMed ID: 28411078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for carbapenemase-producing Enterobacteriaceae in previous carriers readmitted to hospital: evaluation of a change in screening policy.
    Tucker A; George R; Welfare W; Cleary P; Cawthorne J; Dodgson A
    J Hosp Infect; 2019 Oct; 103(2):156-159. PubMed ID: 31039383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient experience of hospital screening for carbapenemase-producing Enterobacteriaceae: A qualitative study.
    King C; Grandison T; Cawthorne J; Currie K
    J Clin Nurs; 2019 Nov; 28(21-22):3890-3900. PubMed ID: 31240778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acceptability of screening for Carbapenemase Producing
    Currie K; King C; McAloney-Kocaman K; Roberts NJ; MacDonald J; Dickson A; Cairns S; Khanna N; Flowers P; Reilly J; Price L
    Antimicrob Resist Infect Control; 2018; 7():144. PubMed ID: 30534365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
    Legeay C; Thépot-Seegers V; Pailhoriès H; Hilliquin D; Zahar JR
    J Hosp Infect; 2018 Aug; 99(4):390-395. PubMed ID: 29438727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.